Skip to main content

Table 1 Relationship between the expression of PRAF3 and clinical features

From: PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma

clinical features esophageal squamous cell carcinoma
  PRAF3-positive n (%) PRAF3-negative n (%) test P
Total 24 33   
Age (year)     
< 60 13/24 (54.2) 19/33 (57.6) 0.0656 0.7979
≥ 60 11/24 (45.8) 14/33 (42.4)   
Gender     
Male 17/24 (70.8) 25/33 (75.8) 0.1738 0.6768
Female 7/24 (29.2) 8/33 (24.2)   
Pathological grading     
Well 11/24 (45.9) 6/33 (18.2) 5.9991 0.0498
Moderately 8/24 (33.3) 12/33 (36.4)   
Poorly 5/24 (20.8) 15/33 (45.4)   
Tumor location     
Upper 1/3 middle 1/3 15/24 (62.5) 23/33 (70.0) 0.3239 0.5693
Lower 1/3 9/24(37.5) 10/33 (30.0)   
Tumor stage     
T1/T2 13/24 (54.2) 8/33 (24.2) 5.347 0.0208
T3/T4 11/24 (45.8) 25/33 (75.8)   
Lymph node metastasis     
Negative 14/24 (58.3) 10/33 (30.3) 4.4785 0.0343
Positive 10/24 (41.7) 23/33 (69.7)